Optimising the programme of cervical cancer screening through the introduction of genome detection of human papillomavirus with women long-term non-participants in existing screening (Q66365): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Changed an Item)
Property / programme
 
Property / programme: Employment, Human Capital and Social Cohesion - CZ - ESF/YEI / rank
 
Normal rank

Revision as of 21:39, 25 March 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Optimising the programme of cervical cancer screening through the introduction of genome detection of human papillomavirus with women long-term non-participants in existing screening
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    9,404,358.31 Czech koruna
    0 references
    376,174.3324 Euro
    10 January 2020
    0 references
    12,124,877.76 Czech koruna
    0 references
    484,995.1104 Euro
    10 January 2020
    0 references
    77.56 percent
    0 references
    1 March 2018
    0 references
    28 February 2021
    0 references
    Ústav zdravotnických informací a statistiky ČR
    0 references
    0 references

    50°4'3.86"N, 14°25'18.62"E
    0 references
    12800
    0 references
    Předložený projekt směřuje k praktickému ověření zdravotnické technologie založené na vědeckých důkazech, která má reálný potenciál zvýšit efektivitu (diagnostickou bezpečnost, kvalitu, účinnost, nákladovou efektivitu) programu screeningu karcinomu děložního hrdla, který je v ČR bohužel stále nezanedbatelnou příčinou úmrtí na nádorové choroby. V případě úspěšného ověření lze očekávat zvýšení kvality programu a zvětšení jeho potenciálního dopadu na snížení úmrtnosti pro karcinom děložního hrdla. (Czech)
    0 references
    The proposed project aims at the practical verification of a health technology based on scientific evidence that has the real potential to increase efficiency (diagnostic safety, quality, efficiency, cost effectiveness) of the cervical cancer screening programme, which is unfortunately still a non-negligible cause of death in cancer. In case of successful verification, an increase in the quality of the programme and an increase in its potential impact on the reduction of the cervical cancer mortality may be expected. (English)
    0 references

    Identifiers

    CZ.03.2.63/0.0/0.0/15_039/0008171
    0 references